Obstetric complications needing blood transfusions may lead to morbidity and mortality if not managed properly. Adverse events associated with blood transfusions including potential infections, transfer of prions, rising costs and possible future problems of availability. Unfortunately, the randomized controlled trials about the blood transfusion during obstetrics are largely unavailable. Hence, the aim of this guideline is to guide appropriate use of blood products so that the affected women are not exposed to unnecessary risk.
Obstetrics hemorrhage remains one of the main causes of maternal mortality. Retrospective clinical scenarios indicate that blood transfusions were either 'too little, too late'. In such cases, women at higher risk of losing greater than 1000ml should receive blood transfusion and intensive care facilities. However, major risk of blood transfusion includes…
